Basic HTML Version
design
Hybrid
Biocompatible degradation
The gentle degradation of the
BIOlute
®
polymer matrix into
CO
2
and H
2
O causes minimal
tissue burden and avoids
inflammation.
Controlled drug release
Immediately following
implantation the drug elution
from BIOlute
®
starts. In vivo
studies show that Orsiro elutes
drug over 12 - 14 weeks.
Invisible backbone
When the BIOlute
®
coating
is gone only a PROBIO
®
sealed stent is left in the
arterial wall.